clindamycin phosphate + benzoyl peroxide
Commercial- Indications
- Acne vulgaris
Company intelligence / Profile preview
Coria Laboratories Ltd. was a privately held specialty pharmaceutical company focused on developing branded prescription and over-the-counter dermatological products such as tretinoin-based therapies for acne, rosacea, dermatoses, hand dermatitis among others. In September 2008, it was acquired by Valeant Pharmaceuticals International and subsequently became part of Bausch Health Companies. Post-acquisition the original entity ceased independent operations, but its product lines continue under new ownership.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coria Laboratories Ltd..